Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 257 | 210 | 245 | 0 | 336 |
| Operating Income | -257 | -210 | -245 | N/A | -336 |
| Pre-tax Income | -257 | -210 | -245 | 0 | -336 |
| Net Income Continuous | -257 | -210 | -245 | N/A | -336 |
| Net Income | $-257 | $-210 | $-245 | $N/A | $-336 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.03 | N/A | -1.15 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.03 | N/A | -1.15 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.03 | N/A | -1.15 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.03 | N/A | -1.15 |
| EBITDA(a) | $-256 | $-210 | $-244 | $N/A | $-336 |